New treatment closer to cancer cure New York - Arabstoday Existing drugs offer new treatment options for a high-risk childhood leukemia subtype of the most common childhood cancer, U.S. researchers said. Dr. Charles Mullighan, an associate member of the St. Jude Children's Research Hospital Department of Pathology, said the discovery of the genetic basis of a high-risk subtype of leukemia showed some patients might benefit from existing targeted therapies, advancing the goal of curing all children with leukemia. The study focused on a subtype of acute lymphoblastic leukemia known as Philadelphia chromosome-like acute lymphoblastic leukemia, or Ph-like ALL, that accounted for as much as 15 percent of childhood acute lymphoblastic leukemia. It is associated with a high risk of relapse and poor outcomes. "One of the next steps will be to continue work on laboratory tests to rapidly identify patients whose cancer cells carry these alterations and to develop clinical trials to test targeted therapies," Mullighan said in a statement. The findings were published online in the journal Cancer Cell.
GMT 10:09 2018 Friday ,19 January
Police raid France's LactalisGMT 14:20 2018 Thursday ,18 January
Suppressing a sneeze can be dangerousGMT 12:23 2018 Wednesday ,17 January
Populists target vaccine decreeGMT 12:39 2018 Tuesday ,16 January
Lactalis feels heat as families rebuffGMT 12:01 2018 Monday ,15 January
Embattled dairy chief breaks silenceGMT 11:26 2018 Sunday ,14 January
One separated Gaza twin diesGMT 11:31 2018 Saturday ,13 January
France laments 'dysfunction'GMT 09:22 2018 Friday ,12 January
Cancer shatters gay marriage dreamsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor